Gen-Probe prevails in Bayer viral diagnostics dispute
This article was originally published in Clinica
Executive Summary
An arbitrator has sided with San Diego nucleic acid testing (NAT) specialist Gen-Probe in its dispute with Bayer HealthCare over their viral diagnostics collaboration. Edward Wallin, of Judicial Arbitration & Mediation Service (JAMS), determined that Gen-Probe should have a joint right with Bayer to distribute qualitative TMA assays for the detection of hepatitis C and HIV-1.